drugset / Trial / NCT04266145

Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty

NCT04266145 ↗

Completed 56 enrolled Mansoura University
RandomizedParallel-groupDouble-blindPrevention

Summary

Shivering increases the cardiac and systemic energy expenditure, oxygen consumption and carbon dioxide production. Definitive prevention and treatment of shivering is necessary to decrease the related complications and increase post-anesthetic comfort.

Timeline

Start
2020-02-29
Primary completion
2022-07-01
Completion
2022-08-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous